Zobrazeno 1 - 10
of 10
pro vyhledávání: '"S Portillo-Haro"'
Publikováno v:
Section 5: Patient safety and quality assurance.
Publikováno v:
Section 4: Clinical pharmacy services.
Autor:
C Castaño-Amores, P Nieto-Gómez, S Portillo-Haro, MT Nieto, X Díaz-Villamarín, CL Dávila-Fajardo
Publikováno v:
Section 4: Clinical pharmacy services.
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance Inflammatory/autoimmune ophthalmic syndromes (IAOS) are often treated with corticosteroids in severe cases. However, in some cases, corticosteroids can be contraindicated, poorly tolerated or ineffective. This situation is c
Autor:
S Portillo Haro, A Rodriguez Delgado, J Cabeza Barrera, P Moreno Rodriguez, P Nieto Gómez, C Castaño-Amores, R Álvarez Sánchez
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance Tofacitinib is an oral JAK inhibitor indicated for the treatment of rheumatoid arthritis, psoriasis arthritis and ulcerative colitis. The efficacy and safety of tofacitinib have been shown in several randomised clinical tria
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance Neurokinin-1 (NK1) receptor antagonist (RA), netupitant, is usually co-administered with the serotonin (5-HT3) RA, palonosetron, to prevent chemotherapy induced nausea and vomiting. Aim and objectives To analyse potential dr
Autor:
P García-Navas, X Díaz-Villamarín, S Portillo-Haro, AE Fernández-Gómez, Cristina Lucía Dávila-Fajardo, Alba Antúnez-Rodríguez
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance Pharmacogenetics allows identification and prediction of different responses to drugs in patients. During the past few years, pharmacogenetic dosing guidelines have been developed and implemented in daily clinical practice a
Autor:
J Cabeza-Barrera, R Álvarez-Sánchez, S Portillo-Haro, E Yuste-Ossorio, J García Villanova, M Núñez-Núñez, R Morón-Romero, N Chueca
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance Exposure to beta-lactam antibiotics due to their hydrophilic properties is widely known to be influenced by the typical pharmacokinetic alterations in critical patients, such as increased volume of distribution and increased
Autor:
R García-Fumero, Miguel Ángel Calleja-Hernández, Cristina Fernández-López, José Expósito-Hernández, S Portillo-Haro
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance Numerous randomised controlled trials (RCT) have been conducted over recent decades to identify the optimal therapeutic option for patients with advanced non-small cell lung cancer (NSCLC). However, only modest clinical bene
Publikováno v:
Section 5: Patient Safety and Quality assurance.
Background and importance Palmoplantar pustulosis (PPP) is a chronic disorder marked by the appearance of recurrent eruptions of fluid filled pustules or blisters on the hands and feet. Its aetiology is unknown and its relationship with psoriasis con